Biocon contests Roche claims on cancer drug

Biocon has lashed out at Roche a day after the Swiss company secured an order from the Delhi High Court barring the Indian company from marketing its new drug, co-developed with Mylan, as a......

Roche's patent pain to be Biocon's gain

Indian firm to soon launch copycat of anti-breast-cancer drug For Swiss pharma major Roche, not pursuing an Indian patent for its anti-breast-cancer drug, Herceptin, might mean a loss of millions......

BDR wrestles Big Pharma in patents match

A month ago, Dharmesh Shah had enough time to spare for day-to-day activities of a lesser-known company -- BDR Pharma -- where he serves as chairman & managing director.However, in the last one......

Biocon Q3 net up 9% at Rs 93 crore

Biotechnology major Biocon on Friday posted a 9.38 per cent increase in its net profit at Rs 92.81 crore (Rs 928.1 million) for the third quarter ended December 31 on the back of overall growth in......